
High-throughput NaV1.9 assays to advance pain drug discovery research launched
Validated drug discovery assays overcome previous challenges in targeting NaV1.9 ion channels for chronic pain signalling. The assays enable researchers to overcome traditional limitations of NaV1.9 screening and generate reproducible and decision-ready data



